Wall Street indices extended gains on Monday to open sharply higher as investors cheered the recent Iran-US breakthrough to end the war. The S&P 500 surged 1.27% or 100 points to 7,531.51, tech-heavy ...

Trigger Point fans ‘so excited’ as ITV released a brand-new trailer ahead of the highly anticipated return. The police drama is making its comeback for its fourth series, with a teaser trailer ...

Indian markets surged on Monday with Sensex up over 1,100 points and Nifty gaining more than 300 points, driven by a global rally after the US–Iran peace deal and a sharp fall in crude oil prices.

June 9 (Reuters) – Alphabet’s Google Cloud said on Tuesday that some customers in India experienced intermittent network disruptions after a fire at ‌a third-party data centre triggered an emergency ...

The probe into Delhi's deadly Flourish Stays hotel fire that killed 22 is examining two possible causes – an unattended oil fryer and a cooking gas leak – while staff response and safety lapses remain ...

After days of speculation over his political future, former Tamil Nadu BJP president K Annamalai on Friday announced the launch of a new political movement and confirmed that he would contest the next ...

AT&T and Citi have a long-standing partnership for co-branded credit cards, and earlier this year, Citi issued a refreshed edition of the AT&T Points Plus® Card, adding a major new bonus category.

Your ruling planet Mercury supports clear thinking, communication, and practical problem-solving throughout the week. Planetary influences help you analyse situations accurately without becoming ...

SAO PAULO, June 3 (Reuters) – An experimental treatment for spinal cord injuries has ignited a frenzy in Brazil, drawing patients from as far off as Mexico to a small-town laboratory, mobilizing the ...

Leaders need more than a growth plan. They need clear threshold lines that show when performance drift, dependency failures, downside pressure, or operating drag should trigger intervention before ...

Lilly's Jake Van Naarden is meeting myeloma experts at ASCO to figure out the best possible path for phase 3 trials of Kelonia's in vivo CAR-T prospect. (Darren Incorvaia) Kelonia Therapeutics has ...